$GENE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSCIENT PHARMACEUTICALS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSCIENT PHARMACEUTICALS CORP. Get notifications about new insider transactions in OSCIENT PHARMACEUTICALS CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 15 2004 | GENE | OSCIENT PHARMACEUT ... | REARDON WILLIAM S | Director | Buy | M | 0.38 | 2,790 | 1,060 | 11,719 | 8.9 K to 11.7 K (+31.25 %) |
Dec 15 2004 | GENE | OSCIENT PHARMACEUT ... | REARDON WILLIAM S | Director | Buy | M | 0.67 | 8,929 | 5,982 | 8,929 | 0 to 8.9 K |
Dec 03 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 1.18 | 12,814 | 15,121 | 156,832 | |
Dec 03 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 0.07 | 122,373 | 8,566 | 518,122 | |
Dec 03 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Sell | S | 3.50 | 10,000 | 35,000 | 41,940 | 51.9 K to 41.9 K (-19.25 %) |
Dec 03 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Buy | M | 1.18 | 12,814 | 15,121 | 51,940 | 39.1 K to 51.9 K (+32.75 %) |
Dec 03 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Sell | S | 3.54 | 95,500 | 338,070 | 39,126 | 134.6 K to 39.1 K (-70.94 %) |
Dec 03 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Buy | M | 0.07 | 122,373 | 8,566 | 134,626 | 12.3 K to 134.6 K (+998.72 %) |
Nov 04 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 0.07 | 641 | 45 | 640,495 | |
Nov 04 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Sell | S | 3.50 | 500 | 1,750 | 12,253 | 12.8 K to 12.3 K (-3.92 %) |
Nov 04 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Sell | M | 0.07 | 641 | 45 | 12,753 | 13.4 K to 12.8 K (-4.79 %) |
Oct 04 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | M | 1.63 | 7,246 | 11,775 | 157,500 | |
Oct 04 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 3.58 | 7,246 | 25,941 | 48,460 | 55.7 K to 48.5 K (-13.01 %) |
Oct 04 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Buy | M | 1.63 | 7,246 | 11,775 | 65,961 | 58.7 K to 66 K (+12.34 %) |
Sep 30 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | M | 1.63 | 17,501 | 28,439 | 164,746 | |
Sep 30 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | M | 1.63 | 17,501 | 28,439 | 182,247 | |
Sep 30 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 3.71 | 17,501 | 64,929 | 48,460 | 66 K to 48.5 K (-26.53 %) |
Sep 30 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Buy | M | 1.63 | 17,501 | 28,439 | 65,961 | 48.5 K to 66 K (+36.11 %) |
Sep 30 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 3.66 | 17,501 | 64,054 | 48,460 | 66 K to 48.5 K (-26.53 %) |
Sep 30 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Buy | M | 1.63 | 17,501 | 28,439 | 65,961 | 48.5 K to 66 K (+36.11 %) |
Sep 28 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | M | 1.63 | 17,501 | 28,439 | 217,249 | |
Sep 28 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 3.77 | 17,501 | 65,979 | 48,460 | 66 K to 48.5 K (-26.53 %) |
Sep 28 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Buy | M | 1.63 | 17,501 | 28,439 | 65,961 | 48.5 K to 66 K (+36.11 %) |
Sep 29 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | M | 1.63 | 17,501 | 28,439 | 199,748 | |
Sep 29 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 3.79 | 17,501 | 66,329 | 48,460 | 66 K to 48.5 K (-26.53 %) |
Sep 29 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Buy | M | 1.63 | 17,501 | 28,439 | 65,961 | 48.5 K to 66 K (+36.11 %) |
Sep 07 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 0.07 | 9,000 | 630 | 1,097,420 | |
Sep 07 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 0.07 | 16,100 | 1,127 | 1,106,420 | |
Sep 02 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 0.07 | 7,000 | 490 | 1,122,520 | |
Aug 31 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 0.07 | 3,000 | 210 | 1,129,520 | |
Aug 26 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 0.07 | 5,500 | 385 | 1,132,520 | |
Aug 26 2004 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Chief Medical Offic ... | Option Exercise | M | 0.07 | 2,500 | 175 | 1,138,020 | |
Jul 06 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | M | 1.63 | 1,500 | 2,438 | 597,367 | |
Jul 01 2004 | GENE | OSCIENT PHARMACEUT ... | KIRBY PAMELA J | Director | Option Exercise | A | 1.49 | 9,047 | 13,480 | 34,047 | |
Jul 01 2004 | GENE | OSCIENT PHARMACEUT ... | KIRBY PAMELA J | Director | Option Exercise | A | 4.97 | 25,000 | 124,250 | 25,000 | |
May 10 2004 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 1.46 | 184 | 269 | 127,665 | |
May 10 2004 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 1.46 | 184 | 269 | 127,665 | |
May 10 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.46 | 184 | 269 | 137,896 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | A | 1.57 | 10,947 | 17,187 | 598,867 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | A | 5.22 | 25,000 | 130,500 | 587,920 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | A | 1.57 | 547 | 859 | 562,920 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.57 | 342 | 537 | 137,712 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.57 | 20,525 | 32,224 | 137,370 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 5.22 | 25,000 | 130,500 | 116,845 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.57 | 547 | 859 | 91,845 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.57 | 342 | 537 | 137,712 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.57 | 20,525 | 32,224 | 137,370 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 5.22 | 25,000 | 130,500 | 116,845 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.57 | 547 | 859 | 91,845 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 1.57 | 15,052 | 23,632 | 127,481 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 5.22 | 25,000 | 130,500 | 112,429 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 1.57 | 547 | 859 | 87,429 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Option Exercise | A | 5.22 | 100,000 | 522,000 | 345,598 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Option Exercise | A | 5.22 | 100,000 | 522,000 | 345,598 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | Chairman, CEO and P ... | Option Exercise | A | 5.22 | 500,000 | 2,610,000 | 1,296,610 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.57 | 19,157 | 30,076 | 83,876 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | REARDON WILLIAM S | Director | Option Exercise | A | 5.22 | 25,000 | 130,500 | 64,719 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RUTTER WILLIAM J | Director | Option Exercise | A | 1.57 | 10,947 | 17,187 | 59,218 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RUTTER WILLIAM J | Director | Option Exercise | A | 5.22 | 10,833 | 56,548 | 48,271 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | RUTTER WILLIAM J | Director | Option Exercise | A | 1.57 | 547 | 859 | 37,438 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | A | 1.57 | 10,947 | 17,187 | 1,106,784 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | A | 5.22 | 10,833 | 56,548 | 1,095,837 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | A | 1.57 | 547 | 859 | 1,085,004 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | LOUCKS VERNON R JR | Director | Option Exercise | A | 1.57 | 342 | 537 | 41,913 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | LOUCKS VERNON R JR | Director | Option Exercise | A | 1.57 | 13,684 | 21,484 | 41,571 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | LOUCKS VERNON R JR | Director | Option Exercise | A | 5.22 | 10,833 | 56,548 | 27,887 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | LOUCKS VERNON R JR | Director | Option Exercise | A | 1.57 | 547 | 859 | 17,054 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Option Exercise | A | 1.57 | 10,947 | 17,187 | 38,013 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Option Exercise | A | 5.22 | 10,833 | 56,548 | 27,066 | |
Apr 16 2004 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Option Exercise | A | 1.57 | 547 | 859 | 16,233 | |
Apr 08 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.64 | 327 | 536 | 91,298 | |
Apr 07 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | M | 1.63 | 10,750 | 17,469 | 562,373 | |
Apr 07 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 5.40 | 1,000 | 5,400 | 48,460 | 49.5 K to 48.5 K (-2.02 %) |
Apr 07 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Grant | A | 1.63 | 1,000 | 1,625 | 49,460 | 48.5 K to 49.5 K (+2.06 %) |
Apr 07 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 5.50 | 9,750 | 53,625 | 48,460 | 58.2 K to 48.5 K (-16.75 %) |
Apr 07 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Grant | A | 1.63 | 9,750 | 15,844 | 58,210 | 48.5 K to 58.2 K (+20.12 %) |
Apr 08 2004 | GENE | OSCIENT PHARMACEUT ... | LOUCKS VERNON R JR | Director | Option Exercise | A | 1.64 | 327 | 536 | 16,507 | |
Apr 05 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | M | 1.63 | 34,000 | 55,250 | 573,123 | |
Apr 05 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 5.50 | 10,000 | 55,003 | 48,460 | 58.5 K to 48.5 K (-17.11 %) |
Apr 05 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Grant | A | 1.63 | 10,000 | 16,250 | 58,460 | 48.5 K to 58.5 K (+20.64 %) |
Apr 05 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 5.45 | 24,000 | 130,894 | 48,460 | 72.5 K to 48.5 K (-33.12 %) |
Apr 05 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Grant | A | 1.63 | 24,000 | 39,000 | 72,460 | 48.5 K to 72.5 K (+49.53 %) |
Apr 05 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | M | 1.63 | 34,000 | 55,250 | 607,123 | |
Apr 05 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 5.51 | 10,000 | 55,143 | 48,460 | 58.5 K to 48.5 K (-17.11 %) |
Apr 05 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Grant | A | 1.63 | 10,000 | 16,250 | 58,460 | 48.5 K to 58.5 K (+20.64 %) |
Apr 05 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Sell | S | 5.40 | 24,000 | 129,499 | 48,460 | 72.5 K to 48.5 K (-33.12 %) |
Apr 05 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Grant | A | 1.63 | 24,000 | 39,000 | 72,460 | 48.5 K to 72.5 K (+49.53 %) |
Mar 02 2004 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | A | 1.93 | 223 | 430 | 1,084,457 | |
Mar 02 2004 | GENE | OSCIENT PHARMACEUT ... | LOUCKS VERNON R JR | Director | Option Exercise | A | 1.93 | 223 | 430 | 16,180 | |
Mar 01 2004 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 1.93 | 223 | 430 | 86,882 | |
Mar 01 2004 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 1.91 | 138 | 264 | 86,659 | |
Mar 01 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.93 | 223 | 430 | 90,971 | |
Mar 01 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.91 | 138 | 264 | 90,748 | |
Mar 01 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | A | 1.93 | 223 | 430 | 641,123 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | A | 6.59 | 14,167 | 93,361 | 1,084,234 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | A | 1.98 | 1,085 | 2,148 | 1,070,067 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | A | 1.98 | 434 | 859 | 1,068,982 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Option Exercise | A | 6.59 | 14,167 | 93,361 | 15,686 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Option Exercise | A | 1.98 | 1,085 | 2,148 | 1,519 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Option Exercise | A | 1.98 | 434 | 859 | 434 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | RUTTER WILLIAM J | Director | Option Exercise | A | 6.59 | 14,167 | 93,361 | 36,891 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | RUTTER WILLIAM J | Director | Option Exercise | A | 1.98 | 1,085 | 2,148 | 22,724 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | RUTTER WILLIAM J | Director | Option Exercise | A | 1.98 | 434 | 859 | 21,639 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | LOUCKS VERNON R JR | Director | Option Exercise | A | 1.98 | 271 | 537 | 15,957 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | LOUCKS VERNON R JR | Director | Option Exercise | A | 6.59 | 14,167 | 93,361 | 15,686 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | LOUCKS VERNON R JR | Director | Option Exercise | A | 1.98 | 1,085 | 2,148 | 1,519 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | LOUCKS VERNON R JR | Director | Option Exercise | A | 1.98 | 434 | 859 | 434 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | A | 1.98 | 434 | 859 | 640,900 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.98 | 271 | 537 | 90,610 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.98 | 434 | 859 | 90,339 | |
Feb 17 2004 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 1.98 | 434 | 859 | 86,521 | |
Feb 05 2004 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Option Exercise | A | 1.93 | 6,128 | 11,812 | 245,598 | |
Feb 05 2004 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Option Exercise | A | 1.93 | 6,128 | 11,812 | 239,470 | |
Feb 05 2004 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | Chairman, CEO and P ... | Option Exercise | A | 1.93 | 8,544 | 16,469 | 796,210 | |
Feb 05 2004 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | Chairman, CEO and P ... | Option Exercise | A | 1.93 | 8,545 | 16,470 | 787,666 | |
Feb 05 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.77 | 151 | 268 | 89,905 | |
Feb 05 2004 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.71 | 156 | 267 | 89,754 |